Quick answer: BPC-157 is a synthetic pentadecapeptide, a chain of fifteen amino acids derived from a protein found in human gastric juice. It is primarily studied in preclinical models for its effects on tissue repair and angiogenesis, with no approved clinical applications or human trials confirming efficacy.
What is BPC-157?
BPC-157 stands for "Body Protection Compound-157" and is a synthetic peptide consisting of fifteen amino acids. It is derived from a naturally occurring protein in human gastric juice. The peptide sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. In research, BPC-157 is synthesized chemically rather than extracted from biological sources [1].
Mechanisms of Action
Preclinical studies suggest BPC-157 may influence several biological pathways related to tissue repair and angiogenesis. In rodent models, it has been observed to promote tendon and ligament healing, muscle regeneration, and new blood vessel formation. Proposed mechanisms include modulation of growth factors such as VEGF (vascular endothelial growth factor), nitric oxide pathways, and cytoprotective effects on endothelial cells [1]. However, these molecular and cellular mechanisms require further validation.
Research Models and Experimental Details
Most research on BPC-157 has been conducted in in vitro assays and rodent models, including rats and mice. Studies have investigated its effects on tendon transection, muscle injury, and gastric lesions. Administration routes in these studies include intraperitoneal, intramuscular, or oral delivery, with dosing varying widely depending on the experimental design. Importantly, these findings have not been replicated in human clinical trials, and the translational relevance remains unestablished [1].
Safety and Toxicity in Preclinical Studies
Available animal studies report that BPC-157 exhibits low toxicity and a favorable safety profile at experimental doses, with no significant adverse effects observed. However, comprehensive toxicological evaluations, including long-term safety and off-target effects, have not been published in peer-reviewed literature as of now [1].
Regulatory and Evidence Status
BPC-157 is not approved by the U.S. Food and Drug Administration (FDA) or other major regulatory agencies for human or veterinary use. There are no registered clinical trials demonstrating its safety or efficacy in humans. The peptide remains classified strictly as a research-use-only compound. Researchers should note that any clinical claims or unregulated use are not supported by current regulatory frameworks or scientific evidence.
Quality Control and Sourcing Considerations
Due to the peptide's synthetic nature and research interest, verifying the quality of BPC-157 is critical. Researchers should request batch-specific Certificates of Analysis (COA) including High-Performance Liquid Chromatography (HPLC) purity data and mass spectrometry confirmation. Stability and storage conditions should follow manufacturer recommendations, typically involving refrigeration and protection from moisture.
Peptide Hackers offers BPC-157 with COAs available for each batch. Local pickup is available by appointment at our Los Angeles and Newport Beach locations. For more information on verifying research peptide vendors, see our guide on How to Verify a Research Peptide Vendor.
Related Peptides in Tissue Repair Research
Other peptides studied for tissue repair include TB-500 (Thymosin Beta-4) and GHK-Cu, each with distinct molecular origins and mechanisms. For comparative information, see our articles on TB-500 and GHK-Cu.
Frequently Asked Questions
What is a peptide?
A peptide is a short chain of amino acids linked by peptide bonds. Peptides differ from proteins primarily in size and complexity. BPC-157 is a synthetic peptide composed of fifteen amino acids.
What is peptide synthesis?
Peptide synthesis is the chemical or enzymatic process of assembling amino acids into peptides. Solid-phase peptide synthesis (SPPS) is commonly used to create synthetic peptides like BPC-157 with precise sequences.
What is the current status of BPC-157 research?
Research is limited to preclinical studies in cell cultures and animal models. No human clinical trials have been completed to confirm safety or efficacy.
Are there any known side effects of BPC-157?
Preclinical studies have not reported significant toxic effects at experimental doses, but comprehensive safety data are lacking.
Can BPC-157 be used clinically?
Currently, BPC-157 is not approved for clinical use and is available only for laboratory research.
All products are for laboratory research only. Not for human or veterinary use.
Sources
BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers — Pharmaceutics (2026). PMID: 42198317
Marine Pharmacology in 2022-2023: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities, Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action — Mar Drugs (2026). PMID: 42042208
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging — Front Aging (2026). PMID: 42021992
For more on vendor verification, see How to Verify a Research Peptide Vendor.
For a comparison with other peptides, see BPC-157 vs TB-500 and TB-500.
For local pickup details, visit our Pickup Locations.
Research Use Only
This article is provided for educational purposes. All peptides discussed are sold for research use only and are not intended for human consumption or therapeutic use.